Pacific Biosciences of California Inc (NAS:PACB)
$ 1.395 +0.020 (+1.45%) Market Cap: 433.29 Mil Enterprise Value: 862.27 Mil PE Ratio: 0 PB Ratio: 140.00 GF Score: 53/100

Q4 2019 Pacific Biosciences of California Inc Earnings Call Transcript

Feb 06, 2020 / 09:30PM GMT
Release Date Price: $4.82 (+2.12%)
Operator

Good afternoon, ladies and gentlemen. Thank you for standing by, and welcome to the Pacific Biosciences of California Fourth Quarter 2019 Earnings Conference Call. (Operator Instructions) As a reminder, this conference call may be recorded.

I would now like to turn the conference over to Trevin Rard. Thank you. Please go ahead.

Trevin Rard
Pacific Biosciences of California, Inc. - Head of IR

Good afternoon, and welcome to the Pacific Biosciences Fourth Quarter and Fiscal 2019 Conference Call. Earlier today, we issued a press release outlining the financial results we will be discussing in today's call, a copy of which is available on the Investors section of our website at www.pacb.com or, alternatively, as furnished on the Form 8-K available on the Securities and Exchange Commission website at www.sec.gov. With me today are Mike Hunkapiller, our Chief Executive Officer; Susan Barnes, our Chief Financial Officer; and Ben Gong, our

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot